Reach Us +1 702 553-3066
Molecular Pathways of Colorectal Carcinogenesis are Promising Mistery? | OMICS International | Abstract
ISSN: 2157-2518

Journal of Carcinogenesis & Mutagenesis
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Molecular Pathways of Colorectal Carcinogenesis are Promising Mistery?

Renata Dobrila Dintinjana1*, Arnela Redzovic2 and Marijan Dintinjana1

1Department for Radiotherapy and Oncology,Clinical Hospital Centre Rijeka, Croatia

2Department of General Practice, Clinical Hospital Centre Rijeka, Croatia

*Corresponding Author:
Renata Dobrila Dintinjana
Department for Radiotherapy and Oncology
Clinical Hospital Center Rijeka
Krešimirova 42, 51000 Rijeka, Croatia
Tel: 00385 98 257 729
Fax: 00385 51 658 391
E-mail: [email protected]

Received date: December 02, 2013; Accepted date: April 17, 2014; Published date: April 25, 2014

Citation: Dintinjana RD, Redzovic A, Dintinjana M (2014) Molecular Pathways of Colorectal Carcinogenesis are Promising Mistery?. J Carcinog Mutagen S10:003. doi: 10.4172/2157-2518.S10-003

Copyright: © 2014 Dintinjana RD, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


The specific etiologic factors and pathogenetic mechanisms, underlying the development of cancers of the colon and rectum appear to be complex and


. Despite the continuous advancement in diagnostic and therapeutic methods, despite the global and national programs for prevention it is evidenced increase in

colorectal cancer

(CRC) incidence and mortality.Further progress is needed in the field of non-invasive diagnostic methods to enable early diagnosis, pre and postoperative staging, and to assist in selecting the most suitable neo-adjuvant and adjuvant therapeutic methods and post-treatment follow-up. There are attempts to "personalise and individualise" anticancer therapy based on presence or absence of specific biomarkers. In this review we will focus on the prevalence, the latest progress made within the genomic and proteomic fields and their significance as possible prognostic and predictive markers in CRC patients.


Recommended Conferences
Share This Page